Holen Sie sich die Stockscreener-App
27.49
2.49%
-0.6836
Hims Hers Health Inc Aktie (HIMS) Neueste Nachrichten
Hims & Hers Health Stock (HIMS) Opinions on Regulatory Scrutiny and AI Potential - Quiver Quantitative
Is FTC Lawsuit Altering The Investment Case For Hims Stock (HIMS)? - simplywall.st
Kaplan Fox Continues to Alert Investors of Hims & Hers Health, Inc. (NYSE: HIMS) to a Class Action Deadline on November 2, 2026 - NewMediaWire
Hims & Hers Health, Inc. Securities Fraud Class Action - GlobeNewswire
Hims & Hers Health, Inc. (HIMS) Gains As Market Dips: What You Should Know - Yahoo Finance
Kaplan Fox Encourages Hims & Hers Health, Inc. (NYSE: HIMS) Investors Seeking Recovery to Contact the Firm Before November 2, 2026 - NewMediaWire
Hims & Hers stock: growth momentum versus margin pressure and a 20.6% fair value discount - Investing.com Canada
Hims & Hers Health, Inc. (HIMS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
Kaplan Fox Encourages Wix.com Ltd. (NASDAQ: WIX) Investors with Significant Losses to Contact the Firm Before September 22, 2026 - GlobeNewswire Inc.
HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit with SBS Law - GlobeNewswire
HIMS & HERS HEALTH, INC. (HIMS) SHAREHOLDER ALERT Bernstein - GlobeNewswire
Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Hims & Hers Health, Inc. (HIMS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Hims & Hers Health (NYSE: HIMS) Faces Securities Class Action After FTC Lawsuit Reveal Drives Stock Sharply Lower -- HBSS - PR Newswire
Bronstein, Gewirtz & Grossman LLC Urges Hims & Hers Health, - GlobeNewswire
Here's Why Teladoc's Integrated Care Business Deserves More Attention - TradingView
2026-09-06 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Hims & Hers Health, Inc. (HIMS) and Encourages Investors to Learn More About the Investigation | NYSE:HIMS | Press Release - Stockhouse
Bronstein, Gewirtz & Grossman LLC Urges Hims & Hers Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - PR Newswire
Kaplan Fox Encourages Hims & Hers Health, Inc. (NYSE: HIMS) Inves - The National Law Review
INVESTOR DEADLINE ALERT: Hims & Hers Health, Inc. (HIMS) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PR Newswire
HIMS Stock Kicks Off September In The Red: FDA’s GLP-1 Alert Steals The Spotlight From Australia Expansion - Stocktwits
Hims & Hers Health Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Hims & Hers Health, Inc.HIMS - PR Newswire
Kaplan Fox Encourages Hims & Hers Health, Inc. (NYSE: HIMS) Investors to Contact the Firm Before the Lead Plaintiff Deadline on November 2, 2026 - NewMediaWire
ROSEN, LEADING TRIAL COUNSEL, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionHIMS - ACCESS Newswire
ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Hims & Hers - GlobeNewswire
DEADLINE ALERT for YSS, HIMS, and UNCY: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders - WBOC TV
Hims & Hers stock price is surging today. A surprising deal with Novo Nordisk is the reason why - Fast Company
Investor relations - HIMS investor relations
FTC Hims and Hers Lawsuit: What the Telehealth Giant Didn't Want You to Know About Your Health Data - lawnews.co.uk
Hims & Hers Health, Inc. Securities Fraud Class Action Result of - The National Law Review
Kaplan Fox Encourages Investors of Hims & Hers Health, Inc. (NYSE: HIMS) to Contact the Firm Before Lead Plaintiff Deadline on November 2, 2026 - newmediawire.com
Is Hims & Hers Health Inc (HIMS) a Bargain After 3.0% Drop? GF V - GuruFocus
Hims & Hers Health shares fall over 3% as sellers reinforce pressure and technical weakness persists - Traders Union
Kaplan Fox Reminds Investors of Hims & Hers Health, Inc. (NYSE: H - The National Law Review
Deadline Alert: Hims & Hers Health, Inc. (HIMS) - GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Hims & Hers Health, Inc.HIMS - PR Newswire
Jefferies Initiates Hims & Hers Health(HIMS.US) With Hold Rating, Announces Target Price $31 - Moomoo
HIMS Investor Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Securities Class Action Lawsuit Against Hims & Hers Health, Inc. - PR Newswire
Will Hims & Hers stock break $29.01 resistance as multiple securities fraud class actions filed? - Traders Union
Hims & Hers Health (NYSE: HIMS) Faces Securities Class - globenewswire.com
Kaplan Fox Encourages Investors of Hims & Hers Health, Inc. (NYSE - The National Law Review
Hims & Hers Investor Sues Over FTC Privacy, Billing Claims - Law360
HIMS INVESTOR ALERT: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead the Hims & Hers Class Action Lawsuit - PR Newswire
Deadline Soon: Hims & Hers Health, Inc. (HIMS) Shareholders - GlobeNewswire
HIMS & HERS HEALTH, INC. (HIMS) INVESTOR ALERT Investors - GlobeNewswire
Hims & Hers Misled Investors Before FTC Pounced, Lawsuit Says - news.bloomberglaw.com
Reasons to Retain Hims & Hers Stock in Your Portfolio for Now - Yahoo Finance
Rosen Law Firm Urges Hims & Hers Health, Inc. (NYSE: HIMS) Stockholders to Contact the Firm for Information About Their Rights - Business Wire
HIMS CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. - GlobeNewswire
Hims & Hers (NYSE: HIMS) insider may sell $98K in stock - Stock Titan
Stockholder Alert: Robbins LLP Informs Investors of the Hims & Hers Health, Inc. Class Action - Business Wire
HIMS INVESTOR ALERT: Class Action Lawsuit Filed on Behalf - GlobeNewswire
Hims and Hers stock rating held at Sector Weight by KeyBanc on AI - Investing.com
Law Offices of Frank R. Cruz Encourages Hims & Hers Health, Inc. (HIMS) Shareholders To Inquire About Securities Fraud Class Action - Business Wire
Fraudulent Weight Loss Drugs: FDA Warns Against Mislabeled GLP-1 Medications - Benzinga
Is Hims & Hers Health Inc (HIMS) a Bargain After 3.9% Drop? GF V - GuruFocus
HIMS DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Hims Investors - GuruFocus
HIMS DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Hims Investors of Securities Class Action Lawsuit Deadline on November 2, 2026 - Eagle-Tribune
FDA warns against unapproved compounded weight-loss drugs, shares of Hims & Hers drop 3.2%. - Pluang
Hims & Hers falls after FDA crackdown on unapproved weight-loss drugs - Yahoo! Finance Canada
Hims & Hers CEO holds 22.6M shares, 9.4% stake | HIMS SEC FilingForm SCHEDULE 13D/A - Stock Titan
Hims & Hers’ Australia Expansion Adds Growth, But Execution Will Be Key - Yahoo Finance
Hims & Hers launches weight-loss drugs in Australia - Investing.com
The FTC Sued Hims & Hers Over Health Data. Now Its Board Faces a Probe Over Billing and Subscriptions - inc.com
Market Shocks Are Not Where Hims & Hers Health Stock Has Fallen Furthest - Yahoo Finance
Hims & Hers offers GLP-1 weight-loss drugs, men's health treatments in Australia - reuters.com
Hims is now in Australia - Hims & Hers Newsroom
Hims Inc.Hims Enters Australia, Marking First Expansion into the Asia-Pacific Market - HIMS investor relations
Hims Enters Australia, Marking First Expansion into the Asia-Pacific Market - Business Wire
A Memecoin Called BONER Has Cornered Half the Tokenized Hims & Hers Float - thedefiant.io
0.20%
0.04%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):